{"entity":{"type":"insider","cik":"0001371742","url":"/insider/0001371742","json_url":"/insider/0001371742.json","name":"Ballantyne Charles Evan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":7,"first":"2006-08-29","last":"2015-09-29","span_basis":"filed_date"},"name_variants":[{"name":"Ballantyne Charles Evan","source":"filing","n_filings":7,"first_seen":"2006-08-29","last_seen":"2015-09-29"}],"transactions":[{"id":8096570,"accession":"0001288123-15-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-15-000039","line_url":"/filing/0001288123-15-000039#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Commmon Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":50500.0,"total_display":"50,500.00","total_whole":"50,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-25","filed_date":"2015-09-29","scope":"insider"},{"id":7017418,"accession":"0001144204-14-033539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-033539","line_url":"/filing/0001144204-14-033539#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":13500.0,"total_display":"13,500.00","total_whole":"13,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-27","scope":"insider"},{"id":8144594,"accession":"0001209191-07-069864","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-07-069864","line_url":"/filing/0001209191-07-069864","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1650.0,"shares_display":"1,650","price_per_share":21.508727272727274,"price_display":"21.51","price_state":"stated","total_value":35489.4,"total_display":"35,489.40","total_whole":"35,489","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-14","scope":"insider","n_lines":9},{"id":6981917,"accession":"0001209191-07-069902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-069902","line_url":"/filing/0001209191-07-069902#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":4400.0,"total_display":"4,400.00","total_whole":"4,400","shares_owned_after":5600.0,"shares_owned_after_display":"5,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-14","scope":"insider"},{"id":7702384,"accession":"0001209191-07-052373","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-052373","line_url":"/filing/0001209191-07-052373","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":26.597333333333335,"price_display":"26.60","price_state":"stated","total_value":39896.0,"total_display":"39,896.00","total_whole":"39,896","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-06","filed_date":"2007-09-06","scope":"insider","n_lines":4},{"id":3559239,"accession":"0001209191-06-064032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-064032","line_url":"/filing/0001209191-06-064032#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":16.79,"price_display":"16.79","price_state":"stated","total_value":10074.0,"total_display":"10,074.00","total_whole":"10,074","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-11","filed_date":"2006-12-11","scope":"insider"},{"id":9262187,"accession":"0001209191-06-047887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-047887","line_url":"/filing/0001209191-06-047887#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001371742","owner_name":"Ballantyne Charles Evan","owner_display_name":"Ballantyne Charles Evan","owner_url":"/insider/0001371742","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":12.46,"price_display":"12.46","price_state":"stated","total_value":4984.0,"total_display":"4,984.00","total_whole":"4,984","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-21","filed_date":"2006-08-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001098972","name":"AGENUS INC","url":"/issuer/0001098972","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2015-09-29","last_seen":"2015-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000894158","name":"Synthetic Biologics, Inc.","url":"/issuer/0000894158","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2014-05-27","last_seen":"2014-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000716646","name":"CLINICAL DATA INC","url":"/issuer/0000716646","role":"Officer (SVP, CFO)","n_filings":5,"first_seen":"2006-08-29","last_seen":"2007-12-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001371742","retrieved_at":"2026-08-27T09:31:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}